Moderna Official Statement: Phase 3 Vaccine Efficacy 94.5 Percent
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
73 products from LG’s HVAC Solutions recognized for superior performance
"This morning, for the first time in the world, a vaccine against the new coronavirus was registered" in Russia - Putin
The first WHO enlisted global clinical Phase 3 trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in UAE
The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market
Archt. Carmelo Casas, signed up to work in partnership with Global-Link MP Events International, Inc. for Interior & Design Manila 2020
VERTECO’s Waterless Urinal wins IWFM Award for Innovation in Technology and Systems
PanU has signed an MoU with South Korea’s Eugene Corporation to explore opportunities to adopt PanU’s artificial intelligence technology platform called AiR
Myanmar looks to have a 17-fold increase in coal power by 2030.
India aims 175,000 MW from solar generation and other renewable sources